NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News $165.49 +1.15 (+0.70%) Closing price 08/26/2025 03:58 PM EasternExtended Trading$165.51 +0.02 (+0.01%) As of 08/26/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock About VanEck Biotech ETF (NASDAQ:BBH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VanEck Biotech ETF alerts:Sign Up Key Stats Today's Range$164.79▼$165.5150-Day Range$150.79▼$167.3252-Week Range$135.34▼$183.64Volume1,702 shsAverage Volume5,610 shsMarket Capitalization$349.19 millionAssets Under Management$346.13 millionDividend Yield0.76%Net Expense Ratio0.35%Aggregate RatingModerate Buy ETF Overview The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry. Read More VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.56%0.54%0.53%Other Expenses0.00%0.47%0.56%0.52%0.56%Total Expense0.35%0.75%0.76%0.73%0.73%Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%Net Expense0.35%0.60%0.63%0.63%0.60% Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBH ETF News HeadlinesVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 37.5% in JulyAugust 19, 2025 | americanbankingnews.comBBH: A Biotech Fund That's Ripe For A Major TurnaroundAugust 8, 2025 | talkmarkets.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.August 27 at 2:00 AM | Timothy Sykes (Ad)BBH- A Biotech Fund That's Ripe for a Major TurnaroundAugust 5, 2025 | finance.yahoo.comVanEck Biotech ETF Dividends | NASDAQ:BBH | BenzingaMay 29, 2025 | benzinga.comBBH: Fear Of Price Controls Is Not The ProblemMay 14, 2025 | seekingalpha.comSee More Headlines BBH ETF - Frequently Asked Questions How have BBH shares performed this year? VanEck Biotech ETF's stock was trading at $156.97 at the beginning of the year. Since then, BBH stock has increased by 5.4% and is now trading at $165.4910. Who are VanEck Biotech ETF's major shareholders? Top institutional investors of VanEck Biotech ETF include Miller Investment Management LP (3.86%), Raymond James Financial Inc. (3.22%), Bank of America Corp DE (2.49%) and Bleakley Financial Group LLC (0.90%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ). Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMVIS US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings25 Fund Statistics Assets Under Management$346.13 million Average Daily Volume$5.62 thousand Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume4 Put Options6 Call Options4 Short Interest3,500 shs Miscellaneous Outstanding Shares2,110,000Beta0.73 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report Top 10 BBH HoldingsAmgen (NASDAQ:AMGN)Holding Weight: 15.35%Gilead Sciences (NASDAQ:GILD)Holding Weight: 12.84%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 8.69%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 6.54%argenex (NASDAQ:ARGX)Holding Weight: 5.36%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 5.35%IQVIA (NYSE:IQV)Holding Weight: 4.87%Insmed (NASDAQ:INSM)Holding Weight: 4.41%Natera (NASDAQ:NTRA)Holding Weight: 4.06%Icon (NASDAQ:ICLR)Holding Weight: 3.56%Full Holdings DetailsBBH Sector ExposureBBH Industry Exposure This page (NASDAQ:BBH) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access